Le Lézard
Classified in: Health, Science and technology
Subjects: HEALTH, MISCELLANEOUS

Philips improves workflow and efficiency with next generation ultrasound systems EPIQ Elite and Affiniti at #RSNA23


November 27, 2023

Amsterdam, the Netherlands and Chicago, USA ? Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today placed workflow and efficiency at the heart of the next generation of its flagship ultrasound systems EPIQ Elite and Affiniti at #RSNA23. Globally, ultrasound users are challenged with increased patient volume and staffing shortages ? exacerbated by more complex cases. The systems feature new automated tools and a common user interface coupled with transducer compatibility across Philips ultrasound systems, including the recently introduced Compact Ultrasound 5000 Series. These latest advances are demonstrating a positive impact on patient and staff satisfaction with customers worldwide by helping to improve workflow and provide greater scanning efficiency.

"At the University of Washington Medical Center, we have multiple locations where we do a wide range of ultrasounds, from general imaging and obstetrics to abdominal, where our sonographers perform as many as 150-170 ultrasound exams in a typical a day," said Dr. Manjiri Dighe, MD, Medical Director of Ultrasound and Adjunct Professor of Obstetrics and Gynecology at the University of Washington Department of Radiology, Seattle, USA. "Using the latest advances from Philips Ultrasound like the next generation Flow Viewer and MVI Super Resolution CEUS, it's easier for me to have increased confidence in my diagnosis and ultimately help my patients get better and faster treatment options. To help us better manage a very heavy throughput of patients, the next generation Auto Scan Assistant also helps the sonographer optimize the image, while reducing the number of keystrokes by more than 50% which has greatly improved our staff satisfaction and the quality of our exams."

"Our next generation ultrasound systems EPIQ and Affiniti address the challenges healthcare systems face every day in dealing with more patients with more complex conditions while enhancing operational efficiency and reducing costs," said Jeff Cohen, General Manager of Ultrasound at Philips. "By providing a consistent platform across our systems, and continually improving workflow, we're able to give clinicians more time to focus on what they do best: caring for their patients."

Next generation of clinical performance, advanced insights and simplified workflows
New features and major enhancements incorporated in Philips' latest ultrasound systems driving advanced visualization and efficiency include:

Demonstrations of Philips' latest EPIQ Elite and Affiniti ultrasound systems, along with live scanning will be available in the Philips Booth #6730 at #RSNA23. Visit Philips at RSNA for more information.

[1] Compared to Philips legacy MVI.
[2] Compared to the predecessor L15-7iO.
[3] When comparing VM10 performance to VM 7 performance.

For further information, please contact:

Kathy O'Reilly
Philips Global Press Office
Tel.: +1 978 221 8919
E-mail: [email protected]

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 70,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments



These press releases may also interest you

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

at 19:54
On July 02, 2024, the BC Government designated Psychotherapy as a Health Profession under the Health Professions Act. The proposal received cabinet approval and was subsequently signed by the Lieutenant Governor. The official order can be viewed...

at 19:52
Whitman-Walker Institute condemns the politically motivated ruling from a federal district court judge that blocks vital nondiscrimination protections for transgender people across the country. Today, a U.S. district court judge in Mississippi issued...

at 19:22
Product: Instant Noodle Issue: Food - Allergen - Peanut Distribution: AlbertaBritish ColumbiaOntario See the affected products and product photos for this recall Company information Five Continents International Ltd. Telephone: 416-292-6766| Fax:...

at 18:45
The Samaritan's Purse DC-8 departed our hangar in Greensboro, North Carolina, yesterday morning, with a 13-member Disaster Assistance Response Team (DART) and 24 tons of life-saving relief for hurricane-devastated residents of Grenada in the south...



News published on and distributed by: